In recent years, the importance of APIs in the global pharmaceutical supply chain has come under scrutiny. Issues such as supply chain transparency, quality assurance, and sourcing reliability have gained prominence, especially following incidents of contamination and shortages that impacted drug availability. As a result, many companies are now prioritizing risk management strategies and investing in more robust quality control measures to safeguard the integrity of their APIs.
While human studies are still in the early phases, preliminary results are encouraging. A few clinical trials have reported that NMN supplementation is safe and well-tolerated, showing promise for increasing NAD+ levels in healthy individuals. However, more substantial clinical data is needed to fully understand its long-term effects and potential health benefits.
Before considering PQQ supplementation, it is advisable to consult with a healthcare professional, especially for individuals with underlying health conditions or those already taking other supplements or medications. Personalized assessment is crucial, as individual health needs and responses to supplements can vary significantly.